Cart
sales@molnova.com
ACHP
CAS No. 406208-42-2
ACHP( —— )
Catalog No. M33778 CAS No. 406208-42-2
ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 103 | In Stock |
|
| 10MG | 154 | In Stock |
|
| 25MG | 255 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 621 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | 2027 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameACHP
-
NoteResearch use only, not for human use.
-
Brief DescriptionACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β.
-
DescriptionACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β. ACHP has anti-HIV-1 activity and inhibits HIV-1 long terminal repeat (LTR)-driven gene expression through inhibition of NF-κB activation, inhibits TNF-α-induced NF-κB (p65) recruitment to the HIV-1 LTR, and inhibits TNF-α-induced NF-κB (p65) recruitment to the HIV-1 LTR. ACHKP has anti-HIV-1 activity and inhibits TNF-α-induced recruitment of NF-κB (p65) to the HIV-1 LTR.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorIκB/IKK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number406208-42-2
-
Formula Weight364.44
-
Molecular FormulaC21H24N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#CC1=C(N=C(C=C1C2CCNCC2)C=3C(O)=CC=CC3OCC4CC4)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bay 65-1942
A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM.
-
BAY32-5915
BAY32-5915 is a selective inhibitor of IKKalpha.
-
HOIPIN-8 sodium
HOIPIN-8 is a potent inhibitor of the linear ubiquitin chain assembly complex (LUBAC) with an IC50 of 11 nM. As a derivative of HOIPIN-1, it exhibits 255-fold greater inhibition of both petit-LUBAC and TNF-α-mediated NF-κB activation compared to HOIPIN-1.
